| Product Code: ETC13272943 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Endoscopic Retrograde Cholangiopancreatography Devices Market was valued at USD 0.4 Billion in 2024 and is expected to reach USD 0.8 Billion by 2031, growing at a compound annual growth rate of 8.70% during the forecast period (2025-2031).
The Global Endoscopic Retrograde Cholangiopancreatography Devices Market is experiencing steady growth driven by increasing incidences of pancreatic and biliary disorders, along with advancements in endoscopic technology. Market players are focusing on developing innovative devices to enhance diagnostic and therapeutic procedures, such as digital cholangioscopy and miniaturized endoscopes. The market is witnessing a shift towards minimally invasive procedures due to benefits like reduced recovery time and lower risk of complications, driving the demand for endoscopic retrograde cholangiopancreatography devices. North America and Europe dominate the market due to well-established healthcare infrastructure and high adoption of advanced medical technologies. However, the Asia Pacific region is expected to witness significant growth due to improving healthcare facilities and rising awareness about endoscopic procedures. Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Cook Medical.
The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market is experiencing significant growth due to the rising prevalence of pancreatic and biliary disorders, as well as advancements in endoscopic technology. Key trends in the market include the increasing adoption of minimally invasive procedures, the development of innovative ERCP devices with improved functionality and precision, and the growing demand for diagnostic and therapeutic endoscopic procedures. Opportunities for market growth lie in expanding applications of ERCP devices, especially in emerging economies, the introduction of robotic-assisted ERCP procedures, and the incorporation of artificial intelligence and machine learning technologies to enhance diagnostic accuracy and procedural outcomes. Manufacturers focusing on product innovation, strategic partnerships with healthcare providers, and geographic expansion are well-positioned to capitalize on the growing demand for ERCP devices globally.
The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market faces several challenges, including the high cost associated with ERCP procedures, limited availability of skilled healthcare professionals proficient in performing ERCP, and the risk of complications such as pancreatitis and hemorrhage during and after the procedure. Additionally, the regulatory requirements for ERCP devices can vary across different regions, leading to delays in product approvals and market entry. Lack of awareness about the benefits of ERCP procedures among patients and healthcare providers also hinders market growth. Moreover, the emergence of alternative diagnostic and therapeutic techniques, such as magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS), poses a competitive challenge to the adoption of ERCP devices in the market.
The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market is primarily driven by the increasing prevalence of pancreatic and biliary disorders, such as pancreatitis, gallstones, and bile duct obstructions. The rising demand for minimally invasive procedures for diagnosing and treating these conditions is fueling the adoption of ERCP devices. Technological advancements in endoscopy equipment, leading to improved imaging quality and procedural efficiency, are also contributing to market growth. Additionally, the growing aging population worldwide, who are more susceptible to these gastrointestinal disorders, is creating a higher demand for ERCP devices. Furthermore, the expanding healthcare infrastructure in emerging economies and the increasing awareness among healthcare providers about the benefits of ERCP procedures are expected to drive the market further.
Government policies related to the Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market primarily focus on regulating the safety, efficacy, and quality of these medical devices to ensure patient safety and promote innovation. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in Europe have established guidelines and requirements for the approval and marketing of ERCP devices. These policies often include rigorous testing and evaluation processes, adherence to quality standards, and post-market surveillance to monitor device performance and address any safety concerns. Additionally, government policies may also address issues related to reimbursement, pricing, and healthcare coverage for ERCP procedures using these devices to facilitate access to essential healthcare services for patients.
The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market is expected to witness significant growth in the coming years, driven by the increasing prevalence of pancreatic and biliary diseases, as well as advancements in technology leading to the development of more efficient and user-friendly devices. The rising adoption of minimally invasive procedures, along with the growing demand for early diagnosis and treatment of gastrointestinal disorders, will further boost market expansion. Additionally, the increasing geriatric population, who are more susceptible to such conditions, will contribute to market growth. However, regulatory challenges and the high cost associated with ERCP devices may hinder market progression to some extent. Overall, the Global ERCP Devices Market is projected to experience steady growth due to the rising demand for minimally invasive procedures and technological advancements in the field.
In the Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, Asia is experiencing significant growth due to the increasing prevalence of gastrointestinal disorders and the rising adoption of advanced medical technologies in countries like China and India. North America dominates the market with a high demand for minimally invasive procedures and a well-established healthcare infrastructure. Europe is also a key market player, driven by the presence of leading medical device manufacturers and a growing geriatric population. The Middle East and Africa region is seeing steady growth, supported by improving healthcare infrastructure and rising awareness about ERCP procedures. Latin America is witnessing moderate growth due to increasing healthcare expenditure and a growing focus on improving diagnostic capabilities in the region.
Global Endoscopic Retrograde Cholangiopancreatography Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market - Industry Life Cycle |
3.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Market - Porter's Five Forces |
3.5 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.8 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.9 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Trends |
6 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, 2021 - 2031 |
6.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Endotherapy Devices, 2021 - 2031 |
6.1.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Endoscopes, 2021 - 2031 |
6.1.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Imaging Devices, 2021 - 2031 |
6.1.5 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Modality, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Single Use, 2021 - 2031 |
6.2.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Standalone, 2021 - 2031 |
6.2.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Handheld, 2021 - 2031 |
6.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Biliary Sphicterectomy, 2021 - 2031 |
6.3.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Biliary Stenting, 2021 - 2031 |
6.3.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Biliary Dilation, 2021 - 2031 |
6.3.5 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Pancreatic Duct Stenting, 2021 - 2031 |
6.3.6 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Pancreatic Sphicterectomy, 2021 - 2031 |
6.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Bile Duct, 2021 - 2031 |
6.4.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Pancreas, 2021 - 2031 |
6.4.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Gall Bladder, 2021 - 2031 |
6.4.5 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Liver, 2021 - 2031 |
6.4.6 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.5.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Ambulatory Centers, 2021 - 2031 |
6.5.5 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Surgical Centers, 2021 - 2031 |
6.5.6 Global Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Endoscopic Retrograde Cholangiopancreatography Devices Market, Overview & Analysis |
7.1 North America Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume, 2021 - 2031 |
7.2 North America Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Modality, 2021 - 2031 |
7.5 North America Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.6 North America Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7 North America Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
8 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography Devices Market, Overview & Analysis |
8.1 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Modality, 2021 - 2031 |
8.5 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Procedure, 2021 - 2031 |
8.6 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
8.7 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
9 Asia Endoscopic Retrograde Cholangiopancreatography Devices Market, Overview & Analysis |
9.1 Asia Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Modality, 2021 - 2031 |
9.5 Asia Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Procedure, 2021 - 2031 |
9.6 Asia Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
9.7 Asia Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
10 Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, Overview & Analysis |
10.1 Africa Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Modality, 2021 - 2031 |
10.5 Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Procedure, 2021 - 2031 |
10.6 Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
10.7 Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
11 Europe Endoscopic Retrograde Cholangiopancreatography Devices Market, Overview & Analysis |
11.1 Europe Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Modality, 2021 - 2031 |
11.5 Europe Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Procedure, 2021 - 2031 |
11.6 Europe Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
11.7 Europe Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
12 Middle East Endoscopic Retrograde Cholangiopancreatography Devices Market, Overview & Analysis |
12.1 Middle East Endoscopic Retrograde Cholangiopancreatography Devices Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Modality, 2021 - 2031 |
12.5 Middle East Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Procedure, 2021 - 2031 |
12.6 Middle East Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
12.7 Middle East Endoscopic Retrograde Cholangiopancreatography Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
13 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Key Performance Indicators |
14 Global Endoscopic Retrograde Cholangiopancreatography Devices Market - Export/Import By Countries Assessment |
15 Global Endoscopic Retrograde Cholangiopancreatography Devices Market - Opportunity Assessment |
15.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Opportunity Assessment, By Modality, 2021 & 2031F |
15.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Opportunity Assessment, By Procedure, 2021 & 2031F |
15.5 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
15.6 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Opportunity Assessment, By End users, 2021 & 2031F |
16 Global Endoscopic Retrograde Cholangiopancreatography Devices Market - Competitive Landscape |
16.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Revenue Share, By Companies, 2024 |
16.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |